Anthony E. Maida III - 03 Sep 2021 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
Chief Clin. Ops. Officer, Director
Signature
/s/ Anthony Maida
Issuer symbol
OTLC
Transactions as of
03 Sep 2021
Net transactions value
$0
Form type
4
Filing time
08 Sep 2021, 17:00:50 UTC
Previous filing
16 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OTLC Stock Options Award $0 +600,000 $0.000000 600,000 03 Sep 2021 Common Stock 600,000 $0.1393 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest as follows: (i) 1/5th on September 30, 2021; (ii) 1/5th on December 31, 2021; (iii) 1/5th on March 31, 2022; (iv) 1/5th on June 30, 2022; and (v) 1/5th on September 30, 2022.